CIK 0001720893 · Non-accelerated filer<br>Smaller reporting company
BioXcel Therapeutics, Inc.
Sign in to watch- Ticker
- BTAIQ
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821386754
- Phone
- 203-643-8060
- Business address
- 555 LONG WHARF DRIVE, NEW HAVEN, CT, 06511
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-03 | Mehta Vimal CEO, President, Secretary | Purchase | +500 | $5.20 | $3K | 2,000 |
| 2018-12-03 | Steinhart Richard I Chief Financial Officer | Purchase | +500 | $5.20 | $3K | 1,500 |
| 2018-11-30 | Steinhart Richard I Chief Financial Officer | Purchase | +500 | $5.00 | $3K | 1,000 |
| 2018-11-30 | Yocca Frank Chief Scientific Officer | Purchase | +450 | $5.20 | $2K | 950 |
| 2018-11-30 | Mehta Vimal CEO, President, Secretary | Purchase | +300 | $5.04 | $2K | 300 |
| 2018-11-30 | Mehta Vimal CEO, President, Secretary | Purchase | +300 | $5.05 | $2K | 600 |
| 2018-11-30 | Mehta Vimal CEO, President, Secretary | Purchase | +100 | $5.17 | $517 | 700 |
| 2018-11-30 | Mehta Vimal CEO, President, Secretary | Purchase | +300 | $5.20 | $2K | 1,000 |
| 2018-11-29 | Nandabalan Krishnan Director | Purchase | +1,000 | $4.92 | $5K | 1,000 |
| 2018-11-29 | Yocca Frank Chief Scientific Officer | Purchase | +500 | $5.02 | $3K | 500 |
| 2018-11-29 | Steinhart Richard I Chief Financial Officer | Purchase | +500 | $5.00 | $3K | 500 |
| 2018-07-02 | MUELLER PETER Director | Gift | −90,000 | 119,795 | ||
| 2018-07-02 | MUELLER PETER Director | Gift | +90,000 | 90,000 | ||
| 2018-03-12 | Mehta Vimal CEO, President and Secretary | Purchase | +2,000 | $11.00 | $22K | 2,000 |
| 2018-03-12 | Laumas Sandeep Director | Grant or award · Stock Options | +37,209 | 124,188 | ||
| 2018-03-12 | Steinhart Richard I Chief Financial Officer | Grant or award · Stock Options | +32,232 | 116,130 | ||
| 2018-03-12 | MUELLER PETER Director | Grant or award · Stock Options | +37,209 | 161,397 | ||
| 2018-03-12 | Yocca Frank Chief Scientific Officer | Grant or award · Stock Options | +36,498 | 185,808 | ||
| 2018-03-12 | O'Neill Vincent Chief Medical Officer | Grant or award · Stock Options | +31,047 | 155,472 |
Page 29 of 29 · 579 trades